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 Abstract 
 Background: Nocturnal hypertension, male gender, age and arterial stiffness are important 
risk factors for cardiovascular morbidity and mortality. The objective of this study was to as-
sess arterial stiffness in nocturnal hypertensive or normotensive men and women >40 years 
of age.  Methods: Twenty-four-hour ambulatory blood pressure monitoring was performed in 
144 men and 137 women. Eighty-eight subjects were between 40 and 49 years old (53% men), 
98 were between 50 and 59 years old (55% men) and 95 were >60 years old (45% men). They 
were classified as nocturnal hypertensive if their average night systolic blood pressure and/
or diastolic blood pressure was >120/70 mm/Hg. Arterial stiffness was assessed by the Am-
bulatory Arterial Stiffness Index (AASI), which is calculated as 1 minus the slope of diastolic 
on systolic blood pressure during the 24-hour recording period. Results were analyzed by 
analysis of covariance and were adjusted for 24-hour mean arterial pressure, the presence of 
antihypertensive treatment, height and heart rate.  Results: Women showed a higher AASI 
compared to men, independently of age. In men, the AASI increased with age, being higher 
in nocturnal hypertensive than in nocturnal normotensive subjects, independently of age. 
Nocturnal hypertensive women showed higher AASI values than their respective nocturnal 
normotensive controls in the 50- to 59-year and >60-year age groups only.  Conclusion: The 
results show that arterial stiffness is higher among nocturnal hypertensive subjects, espe-
cially in women >50 years old.  © 2015 S. Karger AG, Basel 
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 Introduction 
 Age is an important risk factor for cardiovascular mortality  [1, 2] . Although men have a 
higher lifetime cardiovascular risk, the age-related risk increase is steeper in women after the 
menopause compared to men  [3, 4] .
 Arterial compliance is lower in the elderly  [5, 6] . Deposition of collagen in the intimal layer 
of the arterial wall by smooth muscle cells results in progressive reduction in arterial compliance 
 [7] . Metabolic changes leading to increased body weight, serum cholesterol and insulin resis-
tance as well as to sympathetic nervous system overactivity and baroreceptor dysfunction 
contribute to the development of arterial stiffness in older adults  [7] . This condition, affecting 
15–25% of people >40 years of age, substantially increases the cardiovascular risk  [7, 8] .
 Arterial stiffness is measurable by a number of techniques, including pulse-wave velocity 
and central or peripheral augmentation indexes  [9] . Recently, the Ambulatory Arterial 
Stiffness Index (AASI) has been developed and validated  [5, 10] . It is calculated from systolic 
(SBP) and diastolic blood pressure (DBP) recordings obtained by 24-hour ambulatory blood 
pressure monitoring (ABPM)  [5] . The AASI is an independent predictor of cardiovascular 
mortality, especially of fatal stroke in ambulatory normotensives  [10] , suggesting that it may 
be an early indicator of arterial stiffness before sustained hypertension develops  [11] .
 In addition, nocturnal hypertension is a significant predictor of cardiovascular mortality 
and has been demonstrated to be more accurate than daytime hypertension  [12–14] . Blunted 
nocturnal blood pressure fall is related to the lack of appropriate nighttime parasympathetic 
activation and sympathetic inactivation  [12, 13, 15] . Since endothelial dysfunction is common 
among nocturnal hypertensives  [16] and an increased proinflammatory activity is demon-
strable in this group  [17] , a connection between nocturnal hypertension and arterial stiffness 
can be postulated.
 This study aimed to compare arterial stiffness, measured by the AASI, among men and 
women >40 years old suffering from nocturnal hypertension to that of healthy controls.
 Methods 
 Sample 
 Two-hundred and eighty-one individuals >40 years old underwent ABPM. Subjects who 
suffered from terminal renal insufficiency, significant valvular disease, cardiomyopathy, 
uncontrolled diabetes, hypo- or hyperparathyroidism or congestive heart failure were not 
included in the study. People undergoing corticosteroid, antineoplastic, anticoagulant, insulin, 
oral antidiabetic or digitalic treatment were also excluded as well as those whose ABPM was 
shorter than 23 h or lacked two or more consecutive readings. None of the subjects worked 
during the nighttime hours or in shift work schedules.
 Participants were divided according to age: 40–50 years old, 50–60 years old and >60 
years old.
 24-Hour ABPM 
 Noninvasive ABPM was performed on a normal weekday by means of an automatic ABP 
monitor Spacelab 90207 (Spacelab Medical Inc., USA) validated by the Association for the 
Advancement of Medical Instrumentation (AAMI) and the British Hypertension Society (BHS) 
 [18, 19] . The monitor was placed on the nondominant arm and set to take blood pressure and 
heart rate readings every 20 min from 06: 00 to 22: 00 h and every 30 min for the remaining 
time. Subjects were asked to complete a 24-hour diary during the day of the recording, which 
served to define daytime and nighttime periods.
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 Patients were included in the diurnal normotensive group if their SBP/DBP was <135/85 
mm Hg and they were not under antihypertensive treatment  [20] . Nocturnal hypertension 
was defined as a nocturnal SBP >120 and/or a DBP >70 mm Hg  [21] .
 Ambulatory Arterial Stiffness Index 
 The AASI was calculated as 1 minus the slope of the DBP to SBP linear regression coeffi-
cient  [5, 10] . The linear coefficient was obtained by the least squares technique. All the 
recordings from the 24-hour study span were included in the regression.
 Statistical Analysis 
 An analysis of variance and a χ 2 test were employed to compare the variables among the 
studied groups. An analysis of covariance (ANCOVA) was used to analyze differences in the 
AASI according to sex, age and occurrence of nocturnal hypertension, independently from the 
covariates (24-hour mean blood pressure, antihypertensive treatment, heart rate and height).
 Results 
 The mean age (± SD) of the 281 studied subjects was 56 ± 10 years. Fifty-seven percent 
of the subjects were diurnal hypertensives. The prevalence of nocturnal hypertension was 
46% in diurnal hypertensives and 7% in normotensives. Other characteristics of the studied 
sample are summarized in  table 1 . The AASI correlated positively with age (p < 0.001) and 
24-hour SBP (p < 0.01) and negatively with 24-hour DBP. Height was not associated with the 
AASI.
 Table 1.  Sample characteristics
40 – 49 years
(n = 88)
50 – 59 years
(n = 98)
>60 years
(n = 95)
p value
Male 47 (53) 54 (55) 43 (45) <0.3
BMI 27.7 ± 4.8 26.9 ± 3.5 27.3 ± 4.3 <0.4
Height, cm 170 ± 10 168 ± 9 165 ± 9*, # <0.001
AASI 0.22 ± 0.14 0.30 ± 0.14* 0.36 ± 0.13*, # <0.001
Daytime BP
Systolic 129.2 ± 13.2 133.5 ± 13.8* 135.4 ± 11.2* <0.004
Diastolic 84.9 ± 10.5 86.1 ± 10.0 81.2 ± 7.5*, # <0.001
Nighttime BP
Systolic 114.0 ± 12.1 115.8 ± 14.5 120.1 ± 12.6* <0.006
Diastolic 69.4 ± 9.7 69.8 ± 10.4 67.6 ± 8.5 <0.2
24-hour BP
Mean BP 94.6 ± 10.4 96.5 ± 10.4 94.5 ± 7.4 <0.2
Heart rate 76.6 ± 8.3 73.7 ± 8.7 71.8 ± 10.9* <0.002
Diurnal hypertension
Untreated 25 (28) 32 (33) 15 (16) <0.001
Treated 19 (22) 33 (23) 46 (59)
Nocturnal hypertension 22 (25) 28 (29) 33 (35) <0.3
 Data are means ± SD or n (%). BMI = Body mass index.
* p < 0.05, vs. the 40- to 49-year age group; # p < 0.05, vs. the 50- to 59-year age group (ANOVA followed 
by Bonferroni).
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 Women showed a higher AASI compared to men (mean ± SEM, 0.32 ± 0.01 vs. 0.27 ± 0.01, 
respectively; p < 0.02), independently of age. In men, ANCOVA indicated that the AASI was 
higher in the older groups (40–49 years: 0.22 ± 0.02; 50–59 years: 0.27 ± 0.03; >60 years: 0.38 
± 0.02; p < 0.001) and in the nocturnal hypertensive subjects compared to nocturnal normo-
tensives, independently of age (0.33 ± 0.02 and 0.24 ± 0.02, respectively; p < 0.01;  fig. 1 ). In 
contrast, the AASI was higher in nocturnal hypertensive women in the 50- to 59-year age 
group (nocturnal hypertensives: 0.47 ± 0.06; normotensives: 0.30 ± 0.02; p < 0.05) and in the 
>60-year age group (nocturnal hypertensives: 0.45 ± 0.03; normotensives: 0.33 ± 0.03; p < 
0.05) but not in the 40- to 49-year age group (nocturnal hypertensives: 0.29 ± 0.05; normo-
tensives: 0.24 ± 0.02; p < 0.1), as observed in  figure 1 .
 Discussion 
 Foregoing results indicate that the AASI increased with age and was higher in nocturnal 
hypertensive subjects. A distinctive pattern of the AASI was found in men and women. 
Nocturnal hypertensive males showed a higher AASI, independently of age. On the contrary, 
only nocturnal hypertensive women >50 years old showed a higher AASI compared to 
nocturnal normotensive women, whereas no such difference was found in the younger group.
 The AASI is a new index of arterial stiffness that correlates accurately with most frequently 
used methods for measuring arterial stiffness. Indeed, it may outdo them mainly because it is 
performed along a regular day and in the individual’s natural environment  [5] . The AASI may 
depend on the mechanical properties of small arterioles  [11] .
 Arterial stiffness depends on the artery characteristics (i.e. wall structure, function and 
lumen size) and the distending pressure  [5, 22] . As the BP changes during the 24-hour span, 
the AASI is capable of evaluating arterial stiffness with varying distending pressures.
 The AASI is a powerful predictor of total cardiovascular and stroke mortality  [10] and is 
clearly superior to pulse pressure. Recently, the AASI has been shown to be a good predictor 
of end-organ damage, such as renal damage, microalbuminuria, left ventricular hypertrophy 
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 Fig. 1. The AASI in men ( a ) and women ( b ) >40 years old. The difference between nocturnal normotensive 
(⚫) and hypertensive (⚪) subjects was evaluated by ANCOVA adjusted for 24-hour mean arterial pressure, 
heart rate, height and antihypertensive treatment.  * p < 0.05;  # p < 0.06. Data shown are means ± SEM. 
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and carotid abnormalities in untreated hypertensive individuals  [23, 24] . These results 
suggest that the AASI should be taken into account when evaluating cardiovascular risk.
 In our study, the AASI was higher among nocturnal hypertensive subjects. It could be 
argued that these results are related to increased 24-hour blood pressure, as an increased 
distending pressure would produce arterial stiffness  [22] . However, ANCOVA allowed us to 
control any possible effects of the differences in the average mean arterial pressure and anti-
hypertensive treatment among the age and sex groups, ruling out that possibility.
 Nocturnal hypertension is a significant independent cardiovascular risk factor, even 
more powerful than daytime elevated blood pressure  [12, 14] . In support of the present 
results, the lack of a nocturnal BP fall has been related to the thickening of the intimal layer 
of the common carotid artery, which reduces its distensibility  [25, 26] . Nocturnal hyper-
tensive subjects showed an increase in some indexes of endothelial damage (e.g. ICAM-1 and 
von Willebrand factor) and hypercoagulability (D-dimer and plasminogen activator inhibitor), 
independently from daytime blood pressure values  [17] . These data support the hypothesis 
that in nocturnal hypertensive subjects, vascular intimal fibrosis can result from endothelial 
damage, which reduces vessel distensibility.
 The findings that nighttime hypertension was not associated with an increased AASI in 
women <40 years old can be related to the ovarian cycle status. Estrogenic deprivation in the 
postmenopausal period is related to significant deterioration in endothelial function and 
arterial stiffness, which can be reverted by a hormone replacement therapy  [27, 28] . Moreover, 
the postmenopausal period is associated with a change in the salt sensitivity status, leading 
to increased volume load, arterial stiffness and nocturnal hypertension  [28–30] , supporting 
the results herein reported. Although women’s hormonal status could not be evaluated in this 
study, it can be assumed that after 50 years of age, most women are already postmenopausal 
 [31] . Antihypertensive treatment reduces arterial stiffness by two major mechanisms  [32] . 
By lowering peripheral resistance, it lowers the intra-arterial volume with a concomitant 
reduction in the arterial stiffness  [32] . Additionally, by interfering with systems involved in 
the vascular growth control (e.g. the renin-angiotensin system), a reduction in arterial fibrosis 
occurs, therefore increasing the vessel’s distensibility  [32, 33] .
 In summary, nocturnal hypertension was related to an increase in arterial stiffness in 
men of all ages and in women >50 years old. Thus, it would be advisable to monitor arterial 
stiffness periodically in nocturnal hypertensive patients. The AASI comes at no cost with 
24-hour ABPM and is a significant cardiovascular morbidity and mortality predictor, making 
it the best choice for arterial stiffness evaluation and follow-up.
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